BPC-157 and TB-500 target complementary aspects of tissue repair. BPC-157 accelerates fibroblast activity and modulates the nitric oxide system for localised repair. TB-500 drives broader angiogenesis via actin upregulation and reduces systemic inflammation. Together they address both the local repair environment and the systemic healing response.
Overview
Reconstitution Table (2 mL each mL BAC water u2192 5 mg + 10 mg)
| Compound | Dose | Frequency |
| BPC-157 | 250 mcg | Twice daily (SC) |
| TB-500 | 2 mg | Twice weekly (SC or IM) |
Reconstitute each vial separately. BPC-157 (5 mg / 2 mL u2192 2,500 mcg/mL). TB-500 (10 mg / 2 mL u2192 5 mg/mL). Can be combined in the same syringe for injection convenience u2014 check compatibility.
Loading phase: higher TB-500 dose (4u20136 mg twice weekly) for weeks 1u20134. Maintenance: 2 mg twice weekly. Pair with BPC-157 throughout. Research use only.
Potential Benefits & Side Effects
Potential Benefits
- Comprehensive tissue repair coverage
- Reduced healing time vs either alone
- Anti-inflammatory and angiogenic synergy
- Systemic + local action
Possible Side Effects
- Combined side-effect profile of both peptides
- Mild fatigue in loading phase
Storage Instructions
Lyophilized Powder
- Short-term (<3 months): Refrigerate at 2u00b0Cu20138u00b0C
- Long-term: Freeze at u221220u00b0C or lower
- Protect from light and moisture
- Allow vial to reach room temperature before opening
Reconstituted Solution
- Refrigerate at 2u00b0Cu20138u00b0C u2014 do not freeze
- Use within 28 days when reconstituted with BAC water
- Always use sterile technique when drawing doses
References
Important Note
This protocol guide is for educational and research purposes only. It is not medical advice. Always consult a qualified healthcare professional before using any peptide compound.